Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph early_phase_1
1
25%
Ph phase_2
1
25%
Ph phase_3
1
25%
Ph phase_1
1
25%

Phase Distribution

2

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(3)

Detailed Status

Withdrawn2
Completed1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (25.0%)
Phase 11 (25.0%)
Phase 21 (25.0%)
Phase 31 (25.0%)

Trials by Status

completed125%
terminated125%
withdrawn250%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_2

VE202 in Patients With Mild-to-Moderate Ulcerative Colitis

NCT05370885
withdrawnearly_phase_1

Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients

NCT04246151
completedphase_1

A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT

NCT04995653
withdrawnphase_3

Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea

NCT02801656

Clinical Trials (4)

Showing 4 of 4 trials
NCT05370885Phase 2

VE202 in Patients With Mild-to-Moderate Ulcerative Colitis

Terminated
NCT04246151Early Phase 1

Oral Vancomycin Versus Probiotics Versus Placebo for Prevention of Clostridium Difficile Infection in Colonized Patients

Withdrawn
NCT04995653Phase 1

A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT

Completed
NCT02801656Phase 3

Fecal Microbiota Transplantation for Primary Clostridium Difficile Diarrhea

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4